Vaginal laser for breast cancer survivors taking aromatase inhibitors did not improve sexual function, painful intercourse or vaginal health more than sham treatment at 12 months, according to a randomized clinical trial. Both groups improved while receiving nonhormonal supportive care, raising important questions about the cost and additional value of vaginal laser procedures.